Silvia Ingala Medicine and Surgery (University of Pavia)
Postdoctoral Researcher, Rigshospitalet, Copenhagen · Denmark
Editorial leadership for Journal of Alzheimer's Research and Therapy ISSN 2998-4211
Research interests
- Neuroimaging
- Alzheimer's Disease
- Dementia
- Neurodegeneration
- Radiology
- Neuroradiology
Biography
Dr. Silvia Ingala is a Postdoctoral Researcher at Rigshospitalet, Copenhagen, Denmark, specializing in neuroimaging, Alzheimer's disease, dementia, neurodegeneration, and radiology. She completed her education at the University of Pavia and has contributed to the development of advanced imaging methodologies for neurodegenerative research. Her work includes investigations into the detection of amyloid-related imaging abnormalities with edema or effusion (ARIA-E) in Alzheimer's patients receiving immunotherapy, employing subtraction MRI techniques to enhance diagnostic accuracy. Dr. Ingala is notably recognized for her contribution to "ExploreASL: An image processing pipeline for multi-center ASL perfusion MRI studies" (2020), which has been cited 124 times, and has authored over 11 indexed publications in her field.
Selected publications
- ExploreASL: An image processing pipeline for multi-center ASL perfusion MRI studies 2020 cited 124×
- Application of the ATN classification scheme in a population without dementia: Findings from the EPAD cohort 2021 cited 77×
- Amyloid-driven disruption of default mode network connectivity in cognitively healthy individuals 2021 cited 56×
- Brain miliary enhancement 2020 cited 18×
- "It depends": Configuring AI to Improve Clinical Usefulness Across Contexts 2024 cited 13×
- An Automatic DWI/FLAIR Mismatch Assessment of Stroke Patients 2023 cited 6×
Ranked by citation impact (Crossref) where available, newest otherwise · verified via ORCID.
Considering JALR for your work?
This journal is guided by Silvia Ingala (Postdoctoral Researcher, Rigshospitalet, Copenhagen) and a peer-review board of practising researchers. Open access, author-retained copyright (CC BY), and a clear editorial process.